Alison Bourke
IMS Health
Publications 6
#1Anton Pottegård (University of Southern Denmark)H-Index: 22
#2Olaf H. Klungel (UU: Utrecht University)H-Index: 48
Last.Alison BourkeH-Index: 3
view all 12 authors...
#1Alison Bourke (IMS Health)H-Index: 3
#2Andrew Bate (Pfizer)H-Index: 28
Last.Gillian C. HallH-Index: 14
view all 5 authors...
There is an increasing reliance on databases of healthcare records for pharmacoepidemiology and other medical research, and such resources are often accessed over a long period of time so it is vital to consider the impact of changes in data, access methodology and the environment. The authors discuss change in communication and management, and provide a checklist of issues to consider for both database providers and users. The scope of the paper is database research, and changes are considered ...
8 CitationsSource
#1Alison BourkeH-Index: 3
#2Andrew BateH-Index: 28
Last.Gillian C. HallH-Index: 14
view all 5 authors...
8 CitationsSource
#1Gillian C. HallH-Index: 14
#2Brian C. Sauer (UofU: University of Utah)H-Index: 20
Last.Robert Lo Casale (MSD: Merck & Co.)H-Index: 1
view all 6 authors...
The use of healthcare databases in research provides advantages such as increased speed, lower costs and limitation of some biases. However, database research has its own challenges as studies must be performed within the limitations of resources, which often are the product of complex healthcare systems. The primary purpose of this document is to assist in the selection and use of data resources in pharmacoepidemiology, highlighting potential limitations and recommending tested procedures. This...
109 CitationsSource
#1Alison BourkeH-Index: 3
Last.Joanna LemH-Index: 1
view all 32 authors...